Recombinant Escherichia coli O17:K52:H18 tRNA pseudouridine synthase A (truA)

What is tRNA pseudouridine synthase A (TruA) in E. coli?

TruA is an enzyme belonging to the pseudouridine synthase family that catalyzes the site-specific isomerization of uridine to pseudouridine in tRNA molecules. In E. coli, TruA specifically modifies position 39 in various tRNAs, as verified by multiple detection methods including pseudouridine-specific chemical derivatization and liquid chromatography tandem mass spectrometry (LC-MS/MS) . The enzyme contains a catalytically essential aspartate residue, which is conserved across all pseudouridine synthases and is critical for the isomerization reaction .

The truA gene encodes this enzyme, and when complemented in ΔtruA strains, it restores pseudouridine modification at position 39 in tRNAs. This has been demonstrated through comparative analysis of cyanoethylation patterns in wild-type and mutant strains, confirming TruA's specific function in tRNA modification .

How does TruA differ from other pseudouridine synthases in E. coli?

E. coli contains several pseudouridine synthases that modify specific positions in different RNA molecules. These enzymes exhibit varying substrate specificities and modification sites:

Unlike some other pseudouridine synthases like RluA that modify positions in both tRNA and rRNA, TruA exhibits specificity primarily for tRNAs, particularly at position 39 . The enzyme recognition mechanism relies on the structural context of the target site rather than simple sequence recognition, allowing TruA to modify this position across multiple tRNA species.

What are reliable methods for detecting pseudouridine modifications in tRNA?

Detecting pseudouridine modifications requires specialized techniques due to the mass equivalence between uridine and pseudouridine. The following methodologies have proven effective for reliable detection:

• Chemical Derivatization with Carbodiimide (CMCT): Pseudouridine reacts specifically with CMCT (N-cyclohexyl-N'-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate), forming a stable adduct that can be detected through reverse transcription stops or mass spectrometry .

• Cyanoethylation with Acrylonitrile: Pseudouridine can be specifically derivatized with acrylonitrile, adding approximately 53 Da per pseudouridine, which can be detected by mass spectrometry . This method is particularly effective for mapping pseudouridine positions in known sequences.

• LC-MS/MS Analysis of RNase Digests: Digestion of tRNA with specific RNases (like RNase T1) followed by liquid chromatography tandem mass spectrometry provides high-resolution mapping of modifications. Analysis of collision-induced dissociation (CID) MS/MS data from mass-selected precursor ions can pinpoint the exact position of pseudouridine modifications .

• Comparative Analysis in Knockout Strains: Analyzing tRNA from pseudouridine synthase knockout strains (e.g., ΔtruA) compared to wild-type helps identify which enzyme is responsible for specific modifications. Complementation experiments verify the function of the suspected enzyme .

When implementing these techniques, researchers should carefully control for experimental variability by including appropriate internal standards and controls, such as monitoring pseudouridine modifications at known positions in other tRNAs.

How can recombinant TruA be expressed and purified for in vitro studies?

For optimal expression and purification of enzymatically active recombinant TruA:

• Expression System Selection:

  • Eukaryotic expression systems like yeast appear suitable for producing active recombinant TruA .

  • For E. coli expression, the pET22b vector system has been successfully used for complementation studies .

• Expression Protocol:

  • Clone the truA coding region from E. coli with appropriate restriction sites.

  • Transform into an expression host (BL21(DE3) for E. coli systems).

  • Induce expression with IPTG at lower temperatures (16-18°C overnight) to improve solubility.

  • Include a C-terminal or N-terminal tag (His-tag or GST) for purification.

• Purification Strategy:

  • Lyse cells under native conditions using sonication or French press.

  • Perform affinity chromatography using Ni-NTA (for His-tagged protein) or glutathione resin (for GST-tagged protein).

  • Further purify using ion exchange chromatography to remove contaminating nucleic acids.

  • Conduct size exclusion chromatography for highest purity.

  • Verify purity using SDS-PAGE and activity using in vitro pseudouridylation assays.

• Enzyme Activity Preservation:

  • Include DTT or β-mercaptoethanol in all buffers to maintain the catalytic cysteine residues.

  • Store purified enzyme in buffer containing glycerol (20-50%) at -80°C.

  • Avoid repeated freeze-thaw cycles by preparing single-use aliquots.

How do mutations in truA affect E. coli physiology and pathogenicity?

Disruption of truA and subsequent loss of pseudouridine at position 39 in tRNAs can have significant effects on bacterial physiology:

• Translational Effects: Loss of pseudouridine modifications can compromise translational fidelity and efficiency, particularly for mRNAs rich in codons requiring the modified tRNAs. This effect has been demonstrated using luciferase reporter genes preceded by multiple tyrosine codons .

• Growth Phenotypes: While direct growth phenotypes may not be immediately apparent in laboratory conditions (ΔrluF strains show no growth phenotype ), the translational defects can become significant under stress conditions or in complex host environments.

• Pathogenicity Impact: In pathogenic E. coli strains like O17:K52:H18 (part of clonal group A), modifications in tRNA function could potentially affect the expression of virulence factors. This clonal group has been implicated in extraintestinal infections beyond urinary tract infections, including vertebral osteomyelitis and associated abscesses .

• Stress Response Modulation: tRNA modifications often play roles in stress adaptation. Alterations in TruA function may affect how the bacteria respond to environmental stresses encountered during infection.

For researchers investigating these effects, comparative transcriptomics and proteomics between wild-type and ΔtruA strains under various stress conditions would provide valuable insights into the physiological role of this modification.

What is the relationship between TruA activity and E. coli strain-specific pathogenicity?

E. coli strains exhibit diverse pathogenicity profiles, and the role of TruA may vary depending on the specific pathotype:

• Extraintestinal Pathogenic E. coli (ExPEC): Strains like O17:K52:H18 (clonal group A) can cause diverse non-urinary tract infections . The translation efficiency of virulence factors in these strains may be influenced by TruA activity.

• Diarrheagenic E. coli Strains: Various pathotypes including EPEC, EHEC, and EAEC cause distinct diarrheal syndromes . The expression of pathotype-specific virulence genes might be modulated by tRNA modifications catalyzed by TruA.

• Strain-Specific Translation Profiles: Different E. coli strains have evolved distinct codon usage patterns. The impact of TruA-mediated modifications may therefore vary depending on the codon usage bias of strain-specific virulence genes.

When studying TruA in pathogenic strains, researchers should consider:

• Comparative analysis of truA sequences across pathogenic and non-pathogenic strains

• Assessment of pseudouridine levels in clinical isolates versus laboratory strains

• Investigation of codon usage in virulence genes and the corresponding tRNAs modified by TruA

• Evaluation of virulence factor expression in wild-type versus ΔtruA strains

How can one design experiments to assess the impact of TruA on translation efficiency?

To evaluate TruA's role in translation efficiency, consider these methodological approaches:

• Reporter Gene Constructs:

  • Design synthetic constructs with reporter genes (e.g., luciferase, GFP) preceded by stretches of codons read by TruA-modified tRNAs.

  • Compare expression levels between wild-type and ΔtruA strains.

  • Analyze the effect of varying the number and position of relevant codons .

• Ribosome Profiling:

  • Perform ribosome profiling in wild-type and TruA-deficient strains.

  • Analyze ribosome occupancy along mRNAs, particularly at codons read by TruA-modified tRNAs.

  • Identify genes whose translation is most affected by TruA deficiency.

• In vitro Translation Systems:

  • Establish in vitro translation systems using ribosomes and tRNAs from wild-type and ΔtruA strains.

  • Measure translation rates and accuracy using defined mRNA templates.

  • Assess the rescue effect by adding purified recombinant TruA to the ΔtruA-derived components.

• Polysome Analysis:

  • Compare polysome profiles between wild-type and TruA-deficient strains.

  • Analyze the distribution of specific mRNAs across polysome fractions.

  • Focus on transcripts enriched in codons read by TruA-modified tRNAs.

When implementing these approaches, researchers should carefully control for secondary effects by including appropriate controls and considering the broader cellular context of translation regulation.

What analytical considerations are important when interpreting LC-MS/MS data for pseudouridine detection?

LC-MS/MS analysis of pseudouridine requires careful attention to several technical aspects:

• Sample Preparation Considerations:

  • Complete digestion with RNases (e.g., RNase T1) is critical for generating comparable oligonucleotide fragments .

  • Bacterial alkaline phosphatase (BAP) treatment helps reduce heterogeneity at the 3' ends .

  • Consistent derivatization conditions across samples ensure comparable modification status.

• Data Analysis Parameters:

  • Consider both singly and doubly derivatized species when quantifying modification levels .

  • Monitor signature digestion products from other tRNAs (e.g., tRNA^Phe) as internal controls .

  • Compare peak areas rather than absolute intensities for more reliable relative quantification.

• Interpreting Collision-Induced Dissociation (CID) Data:

  • Analyze both c and y ion series to confirm modification positions .

  • Pay attention to mass shifts corresponding to derivatization agents (e.g., +53 Da for cyanoethylation, +251 Da for carbodiimide) .

  • Consider potential off-target derivatization when interpreting complex spectra.

• Common Challenges and Solutions:

  • False negatives due to insufficient derivatization: Optimize reaction conditions and include known pseudouridine-containing controls.

  • False positives from non-specific modifications: Include samples from knockout strains as negative controls.

  • Interference from abundant RNAs: Employ fractionation techniques to enrich for specific tRNA species before analysis.

How conserved is TruA structure and function across bacterial species?

TruA belongs to a highly conserved family of pseudouridine synthases found across bacteria, with several key features maintained:

• Catalytic Domain Conservation:

  • The catalytically essential aspartate residue is absolutely conserved in all Ψ synthases .

  • The core catalytic domain structure is maintained across diverse bacterial species.

• Substrate Recognition Differences:

  • Despite structural conservation, substrate recognition can vary between species.

  • Some TruA homologs may modify different positions or recognize slightly different structural contexts.

• Functional Significance Across Species:

  • While E. coli ΔtruA strains may not show strong growth phenotypes in laboratory conditions, the impact in other species or under stress conditions may differ.

  • In pathogens, the contribution to virulence may vary depending on the specific virulence mechanism and infection niche.

Researchers investigating TruA across species should consider:

• Complementation studies to assess functional conservation (can TruA from one species complement ΔtruA in another?)

• Structural analysis to identify species-specific features that might affect substrate specificity

• Evaluation of modification patterns in tRNAs across different bacterial species